Logo image
Chronic hepatitis E: A brief review
Journal article   Open access   Peer reviewed

Chronic hepatitis E: A brief review

Arvind R Murali, Vikram Kotwal and Saurabh Chawla
World journal of hepatology, Vol.7(19), pp.2194-2201
09/08/2015
DOI: 10.4254/wjh.v7.i19.2194
PMCID: PMC4561773
PMID: 26380044
url
https://doi.org/10.4254/wjh.v7.i19.2194View
Published (Version of record) Open Access

Abstract

Hepatitis E viral infection has traditionally been considered an acute, self-limited, water borne disease similar to hepatitis A, endemic to developing countries. However, over the past decade, zoonotic transmission and progression to chronicity in human patients has been identified, resulting in persistently elevated transaminase levels, progressive liver injury and cirrhosis. In addition to liver injury, neurological, renal and rheumatological manifestations have also been reported. Chronic hepatitis E occurs mainly in immunosuppressed individuals such as transplant recipients, human immunodeficiency virus patients with low CD4 counts and in patients with hematological malignancies receiving chemotherapy. Diagnosis is established by persistent elevation of hepatitis E virus RNA in the stool or serum. This population often requires treatment with antiviral agents, particularly ribavirin, as spontaneous clearance with reduction in immunosuppression occurs only in about a third of the patients. The purpose of this review, is to further discuss the clinical presentation, and recent advances in diagnosis, treatment and prophylaxis of chronic hepatitis E.
Immunosuppression Chronic liver disease Solid organ transplantation Hematological malignancies Hepatitis E virus

Details

Metrics

Logo image